Status:
UNKNOWN
the Effect of a New Type of Pelvic Floor Rehabilitation Device PHENIX U4+ on the Treatment of Urinary Incontinence
Lead Sponsor:
Peking University People's Hospital
Conditions:
Urinary Incontinence
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Enrolled patients with urinary incontinence in Peking University People's Hospital, Wuhan People's Hospital, Zhongshan People's Hospital, and Jiangsu Maternity and Child Health Hospital in the Departm...
Detailed Description
Use two pelvic floor treatment devices to treat urinary incontinence, collect relevant questionnaires and pelvic floor muscle strength, and compare the two treatment devices.
Eligibility Criteria
Inclusion
- 1) 18 years old and above; 2) Have a history of sexual life; 3) Plan to live locally for a long time; 4) Mild to moderate pressure, urgency or mixed urinary incontinence; 5) The patient agrees to conduct the study and signs an informed consent form.
Exclusion
- Combined pelvic organ prolapse (with extrahymen bulging);
- Obesity (BMI\>28kg/m2, BMI=weight (kg)/height square (m2));
- Uncontrolled asthma and chronic obstructive pulmonary disease (COPD);
- Combined connective tissue disease;
- Women with unclean lochia during pregnancy, within 6 weeks of postpartum and postpartum
- Malignant tumors;
- Combined neurological diseases (patients with epilepsy and dementia);
- Those with a synchronized pacemaker on their chest (biofeedback can be done).
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT05202717
Start Date
January 1 2022
End Date
December 1 2022
Last Update
January 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100044